Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,529 | 608 | 98.1% |
| Education | $340.64 | 12 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $2,313 | 61 | $0 (2024) |
| ITI, Inc. | $2,265 | 86 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $1,742 | 42 | $0 (2024) |
| Lundbeck LLC | $1,691 | 81 | $0 (2024) |
| ABBVIE INC. | $1,649 | 53 | $0 (2024) |
| Allergan, Inc. | $1,472 | 52 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $1,004 | 44 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $889.25 | 57 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $712.21 | 30 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $698.10 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,705 | 94 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($698.10) |
| 2023 | $2,926 | 100 | ITI, Inc. ($727.63) |
| 2022 | $3,033 | 97 | ITI, Inc. ($895.71) |
| 2021 | $1,742 | 70 | ITI, Inc. ($541.16) |
| 2020 | $938.56 | 37 | Allergan, Inc. ($276.77) |
| 2019 | $2,792 | 75 | Otsuka America Pharmaceutical, Inc. ($798.82) |
| 2018 | $2,594 | 95 | Sunovion Pharmaceuticals Inc. ($446.11) |
| 2017 | $1,140 | 52 | Allergan Inc. ($305.29) |
All Payment Transactions
620 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.40 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $125.17 | General |
| Category: CNS | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $124.90 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $33.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.49 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.19 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $97.15 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.59 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.61 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 149 | 1,333 | $232,730 | $112,402 |
| 2022 | 2 | 135 | 1,329 | $220,476 | $114,915 |
| 2021 | 2 | 128 | 1,102 | $174,501 | $96,172 |
| 2020 | 2 | 126 | 1,000 | $157,267 | $74,882 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 958 | $177,230 | $88,512 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 375 | $55,500 | $23,890 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 1,002 | $175,350 | $94,257 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 327 | $45,126 | $20,658 | 45.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 755 | $128,350 | $72,715 | 56.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 347 | $46,151 | $23,458 | 50.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 73 | 791 | $130,515 | $63,760 | 48.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 53 | 209 | $26,752 | $11,122 | 41.6% |
About Dr. Lance Besner, M.D
Dr. Lance Besner, M.D is a Clinical Neuropsychologist healthcare provider based in Erie, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1265433361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lance Besner, M.D has received a total of $17,870 in payments from pharmaceutical and medical device companies, with $2,705 received in 2024. These payments were reported across 620 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($17,529).
As a Medicare-enrolled provider, Besner has provided services to 538 Medicare beneficiaries, totaling 4,764 services with total Medicare billing of $398,372. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Clinical Neuropsychologist
- Other Specialties Psychiatry
- Location Erie, PA
- Active Since 08/10/2005
- Last Updated 11/19/2018
- Taxonomy Code 103G00000X
- Entity Type Individual
- NPI Number 1265433361
Products in Payments
- REXULTI (Drug) $3,487
- VRAYLAR (Drug) $3,068
- CAPLYTA (Drug) $2,963
- AUSTEDO (Drug) $956.09
- TRINTELLIX (Drug) $746.10
- INGREZZA (Drug) $712.21
- LATUDA (Drug) $617.55
- Auvelity (Drug) $527.80
- LYBALVI (Drug) $432.24
- NUEDEXTA (Drug) $419.70
- FANAPT (Drug) $387.13
- Trintellix (Drug) $351.01
- INVEGA SUSTENNA (Drug) $313.53
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $312.17
- Fanapt (Drug) $303.50
- HETLIOZ (Drug) $299.92
- Austedo XR (Drug) $289.34
- ABILIFY MAINTENA (Drug) $249.11
- UZEDY (Drug) $247.07
- ARISTADA (Drug) $177.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Neuropsychologist Doctors in Erie
Mark Hogue, Psy.d, PSY.D
Clinical Neuropsychologist
Dr. Tammy Kordes, Ph.d, PH.D
Clinical Neuropsychologist
Dr. Lamar Neal, Psy.d, PSY.D
Clinical Neuropsychologist
Dr. James Leri, Ph.d, PH.D
Clinical Neuropsychologist
Dr. Renata Harland, Ph.d, PH.D
Clinical Neuropsychologist
Dr. Donna Ziegler, Ph.d, PH.D
Clinical Neuropsychologist